{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T18:11:59Z","timestamp":1777918319726,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T00:00:00Z","timestamp":1692489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.hjc.2023.08.010","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T08:54:08Z","timestamp":1692953648000},"page":"42-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Use of the CHA2DS2-VASc score to predict subsequent myocardial infarction in atrial fibrillation"],"prefix":"10.1016","volume":"78","author":[{"given":"Su-Kiat","family":"Chua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pang-Shuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jien-Jiun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Chun","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juey-Jen","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Ti","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hjc.2023.08.010_bib1","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1001\/jama.2011.659","article-title":"Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation","volume":"305","author":"Conen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.hjc.2023.08.010_bib2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2006.10.062","article-title":"Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study","volume":"49","author":"Miyasaka","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2023.08.010_bib3","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.hjc.2023.08.010_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hjc.2023.08.010_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2023.08.010_bib6","first-page":"1389","article-title":"2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation","volume":"37","author":"Chao","year":"2021","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.hjc.2023.08.010_bib7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCULATIONAHA.108.825380","article-title":"Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop","volume":"119","author":"Benjamin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2023.08.010_bib8","article-title":"Atrial fibrillation and the risk of myocardial infarction: a nationwide propensity-matched study","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.hjc.2023.08.010_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamainternmed.2013.11912","article-title":"Atrial fibrillation and the risk of myocardial infarction","volume":"174","author":"Soliman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.hjc.2023.08.010_bib10","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/CIRCULATIONAHA.114.014145","article-title":"Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"131","author":"Soliman","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2023.08.010_bib11","first-page":"1431","article-title":"Role of the CHADS2 score in acute coronary syndromes: risk of subsequent death or stroke in patients with and without atrial fibrillation","volume":"141","author":"Poci","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.hjc.2023.08.010_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111167","article-title":"Use of CHADS(2) and CHA(2)DS(2)-VASc scores to predict subsequent myocardial infarction, stroke, and death in patients with acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry","volume":"9","author":"Chua","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hjc.2023.08.010_bib13","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/ene.14662","article-title":"Prognostic impact of renal dysfunction on embolic stroke of undetermined source-Role beyond CHA2 DS2 -VASc score: Results from Taiwan Stroke Registry","volume":"28","author":"Chua","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.hjc.2023.08.010_bib14","article-title":"Mortality prediction using CHADS2\/CHA2DS2-VASc\/R2CHADS2 scores in systolic heart failure patients with or without atrial fibrillation","volume":"96","author":"Chen","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.hjc.2023.08.010_bib15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jfma.2021.07.009","article-title":"Prognostic factors of functional outcome in post-acute stroke in the rehabilitation unit","volume":"121","author":"Chen","year":"2022","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.hjc.2023.08.010_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.845949","article-title":"Continuity and Completeness of Electronic Health Record Data for Patients Treated With Oral Hypoglycemic Agents: Findings From Healthcare Delivery Systems in Taiwan","volume":"13","author":"Hsu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hjc.2023.08.010_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10190","article-title":"Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillation","volume":"7","author":"Tsai","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.hjc.2023.08.010_bib18","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2018.02.006","article-title":"The Taiwan Heart Registries: Its Influence on Cardiovascular Patient Care","volume":"71","author":"Wu","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2023.08.010_bib19","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/01.CIR.0000124487.36586.26","article-title":"Renin-angiotensin system gene polymorphisms and atrial fibrillation","volume":"109","author":"Tsai","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2023.08.010_bib20","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/jth.13735","article-title":"C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study","volume":"15","author":"Chang","year":"2017","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.hjc.2023.08.010_bib21","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hjc.2023.08.010_bib22","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1055\/s-0038-1675400","article-title":"Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review","volume":"118","author":"Borre","year":"2018","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.hjc.2023.08.010_bib23","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.mayocp.2014.08.015","article-title":"Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people","volume":"89","author":"Chang","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hjc.2023.08.010_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pcad.2010.04.001","article-title":"The Framingham Heart Study's impact on global risk assessment","volume":"53","author":"Bitton","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.hjc.2023.08.010_bib25","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1606915","article-title":"Acute Myocardial Infarction","volume":"376","author":"Anderson","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hjc.2023.08.010_bib26","first-page":"195","article-title":"Gender differences in management and clinical outcomes of atrial fibrillation patients","volume":"69","author":"Kassim","year":"2017","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.hjc.2023.08.010_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1573403X15666181205110624","article-title":"Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes","volume":"15","author":"Westerman","year":"2019","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.hjc.2023.08.010_bib28","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/2047487317715769","article-title":"Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis","volume":"24","author":"Ruddox","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.hjc.2023.08.010_bib29","article-title":"Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms","volume":"5","author":"Violi","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hjc.2023.08.010_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.hjc.2023.08.010_bib31","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1540-8167.2010.01774.x","article-title":"Update on the association of inflammation and atrial fibrillation","volume":"21","author":"Patel","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hjc.2023.08.010_bib32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.molmed.2011.05.007","article-title":"Inflammatory pathways underlying atrial fibrillation","volume":"17","author":"Friedrichs","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.hjc.2023.08.010_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/europace\/eum284","article-title":"Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation","volume":"10","author":"Duygu","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.hjc.2023.08.010_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/CIRCULATIONAHA.115.017534","article-title":"Embolic myocardial infarction as a consequence of atrial fibrillation: a prevailing disease of the future","volume":"132","author":"Kolodgie","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2023.08.010_bib35","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.jacc.2014.02.541","article-title":"Supply\/demand type 2 myocardial infarction: should we be paying more attention?","volume":"63","author":"Sandoval","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2023.08.010_bib36","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/STROKEAHA.116.013679","article-title":"Left ventricular ejection fraction and risk of stroke and cardiac events in heart failure: data from the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial","volume":"47","author":"Di Tullio","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.hjc.2023.08.010_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/HAE.0000000000000078","article-title":"Managing atrial fibrillation in patients with heart failure and reduced ejection fraction: a scientific statement from the American Heart Association","volume":"14","author":"Gopinathannair","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hjc.2023.08.010_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2020.04.070","article-title":"Predictors of left atrial appendage thrombus despite NOAC use in nonvalvular atrial fibrillation and flutter","volume":"317","author":"Shah","year":"2020","journal-title":"Int J Cardiol"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966623001471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966623001471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:26:41Z","timestamp":1721687201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966623001471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":38,"alternative-id":["S1109966623001471"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2023.08.010","relation":{},"ISSN":["1109-9666"],"issn-type":[{"value":"1109-9666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of the CHA2DS2-VASc score to predict subsequent myocardial infarction in atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2023.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}